Apollo Therapeutics
Cambridge, GB · 4 known investors
Apollo Therapeutics is a biopharmaceutical company that translates academic biology and medical research into new medicines, operating a portfolio of over 20 therapeutic programs with several in clinical development. It runs an R&D platform partnered with leading universities and research institutes, and also in-licenses or acquires clinical-stage programs.
Investors · 4
Also in the syndicate · 1
M&G plc
Funding
SEC filings, press & company announcements$226.5M disclosed across 1 round · 2023
- $226.5MSeries CSep 2023 · 3 sources
Patient Square Capital (lead), M&G plc, Rock Springs Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Apollo Therapeutics do?
- Apollo Therapeutics is a biopharmaceutical company that translates academic biology and medical research into new medicines, operating a portfolio of over 20 therapeutic programs with several in clinical development. It runs an R&D platform partnered with leading universities and research institutes, and also in-licenses or acquires clinical-stage programs.
- Who are Apollo Therapeutics's investors?
- Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, AlbionVC.
- How much funding has Apollo Therapeutics raised?
- Apollo Therapeutics has disclosed $226.5M raised across 1 round.
- Where is Apollo Therapeutics headquartered?
- Apollo Therapeutics is headquartered in Cambridge, GB.